Rationale and design of the expanded combination of evolocumab plus empagliflozin in diabetes: EXCEED-BHS3 trial by Ikaro Breder, Jessica Cunha Breder, Isabella Bonilha, Daniel B. Munhoz, Sheila T. Kimura Medorima, Daniela C. Oliveira, Helison R. do Carmo, Camila Moreira, Anatol Kontush, Francesca Zimetti, Ilaria Zanotti, Luiz Sergio F. Carvalho, Wilson Nadruz, Elza Muscelli, Thiago Quinaglia, Andrei C. Sposito

Connect to this object online.

Diacerein reduces inflammasome activation and SARS-CoV-2 virus replication: a proof-of-concept translational study by Helison R. P. Carmo, Alejandro Rossel Castillo, Isabella Bonilha, Erica I. L. Gomes, Joaquim Barreto, Filipe A. Moura, Filipe A. Moura, Gustavo Gastão Davanzo, Lauar de Brito Monteiro, Stéfanie Primon Muraro, Gabriela Fabiano de Souza, Joseane Morari, Flávia Elisa Galdino, Flávia Elisa Galdino, Natália S. Brunetti, Guilherme Reis-, Victor Corasolla Carregari, Wilson Nadruz, Daniel Martins-, Daniel Martins-, Daniel Martins-, Daniel Martins-, Alessandro S. Farias, Alessandro S. Farias, Alessandro S. Farias, Licio A. Velloso, José Luiz Proenca-Modena, José Luiz Proenca-Modena, Marcelo A. Mori, Marcelo A. Mori, Marcelo A. Mori, Watson Loh, Deepak L. Bhatt, Derek M. Yellon, Sean M. Davidson, Pedro G. De Oliveira, Pedro G. De Oliveira, Pedro M. Moraes-Vieira, Pedro M. Moraes-Vieira, Pedro M. Moraes-Vieira, Andrei C. Sposito

Connect to this object online.